OtoNexus Medical Technologies has a mature and very experienced management and leadership team, with demonstrated expertise in building successful companies, bringing dozens of med-tech products to market, and buying and selling medical devices in the physician segment of the medical industry. The team has extensive expertise in Otitis Media, in Medical Ultrasound, in product development and management, sales and marketing, and in building profitable, high-performing businesses.
The Company also has Board members, business advisors, scientific advisors, and medical advisors who bring great strength and significant background and expertise to assist the company in completing development, performing clinical trials, managing the FDA and CPT/Reimbursement processes, and bringing the product to market, and when appropriate, in approaching large medical device manufacturers and others as potential acquirers of the company.
The company’s Medical Advisory Board consists of the world’s leading experts in the diagnosis, treatment, and research of Otitis Media. This highly active MAB has been essential to the company's work.
Caitlin Cameron: Chair of the Board and Chief Executive Officer. Ms. Cameron is a highly-accomplished senior executive with 30 years’ cross-industry expertise in the Life Sciences, Biotech, Technology, and IT industries. She is a specialist in building high-performing start-up companies. Previously, she held Chair and CEO positions at several Life Sciences and IT companies, building successful businesses and organizations, creating value and maximizing potential in a very short period of time. In addition, she has built organizations known for employee satisfaction, including being selected for the 100 Best Places to Work in Washington.
George A. Gates, MD: Co-founder and Chief Medical Officer. Dr. Gates is a nationally-recognized clinician and medical researcher in otology, with substantial experience in the diagnosis and treatment of otitis media. Dr. Gates is a renowned otolaryngologist and neurotologist, and is an Emeritus Professor at the University of Washington (UW) and former director of the Virginia Merrill Bloedel Hearing Research Center at the UW. In his career, he has authored over 220 peer-reviewed published research reports, review articles, and clinical concepts in Otology/Neurotology. Dr. Gates is the inventor of our technology.
Mark A. Moehring, PhD: Co-founder and Chief Science Officer. Dr. Moehring is an industry-recognized leader in the field of medical ultrasound with over three decades of experience in signal processing and medical ultrasound instrument design. His research and product development focus has been in the field of Doppler ultrasound with primary emphasis in diagnostic and therapeutic cranial and otitis media applications. Dr. Moehring is the inventor of 16 issued patents in ultrasound and hemodynamic monitoring technology.
John Alleman: Chief Technology Officer. Mr. Alleman is a retired Navy submarine officer with a deep background in medical device product development, quality systems, and manufacturing operations, with 20 years of service as a naval officer and over 15 years in private industry. His expertise is in ultrasound product development, project management, risk management, clinical research management, mechanical design and systems engineering. In addition, he has expertise securing US regulatory approvals for 510ks, IDEs, and INDs as well as European CE marks
Gina Kelly: Chief Product Officer. Ms. Kelly is an experienced medical device expert with 20+ years of experience in the ultrasound industry working previously at ATL, Philips Healthcare, and Fujifilm SonoSite, specializing in product strategy and commercialization. Her expertise includes product portfolio strategy, product management and commercialization, market development, clinical engineering, business development, and sales. Ms. Kelly’s clinical experience includes expertise in Doppler ultrasound, and ultrasound for cardiology, radiology, vascular, obstetrics, musculoskeletal, emergency medicine, critical care and regional anesthesiology and medical informatics.
Marc J. Fine, MPH: Vice President, Marketing and Business Management. With more than 30 years experience in the medical devices field, Mr. Fine has had a hand in several major breakthrough initiatives, including Interson's SeeMore USB ultrasound probe, Diasonics (first digital ultrasound imaging system); Teknar (first bi-plane prostate imaging system); SRI International (da Vinci Robotic Surgery System); and Siemens (first 3D C-Arm), among others.
Charlie Corredor, PhD: Vice President, Operations. Dr. Corredor is a biotech entrepreneur and experienced scientist with 8+ years of research experience in medtech and analytical testing with 15 peer-reviewed publications in high impact scientific journals. He has served as a scientific review panelist for various federal grant funding agencies and has managed multiple federally supported grants and contracts in industry and academia. Dr. Corredor holds a dual PhD in Chemical Engineering, Nanotechnology and Molecular Engineering from the University of Washington (UW), where he received the prestigious National Science Foundation Fellowship and National Academy of Sciences–Ford Fellowship. He also holds a business graduate certificate from UW-Foster School of Business in technology development and entrepreneurship.